19 results
424B5
ABOS
Acumen Pharmaceuticals Inc
20 Jul 23
Prospectus supplement for primary offering
4:11pm
they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold securities in street name
8-K
EX-1.1
rhvoe9bxkn47f4 oj
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm
424B5
3a7c4 749wjr
17 Jul 23
Prospectus supplement for primary offering
4:49pm
S-3
76xoffn7ouura9 lp3dn
1 Jul 22
Shelf registration
5:06pm
S-3
EX-1.2
i8bpcp4
1 Jul 22
Shelf registration
5:06pm
10-K
j9pfrawr ae5ijbux1k
28 Mar 22
Annual report
4:51pm
10-Q
jmb3xj
16 Aug 21
Quarterly report
4:51pm
424B4
fkb ureaiuarq
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
EX-10.2
ehw9ze fklbyx
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
EX-1.1
b8ges
24 Jun 21
IPO registration (amended)
8:17am
S-1/A
4zj4m
24 Jun 21
IPO registration (amended)
8:17am
S-1
868jy
9 Jun 21
IPO registration
5:02pm
DRS/A
edocqceyvqj9jtc17vse
14 May 21
Draft registration statement (amended)
12:00am
DRS
2fd nbljfcyiiuv
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next